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ABSTRACT
Background and objective: Cross-sectional and longer-term studies have demonstrated abnor-
mal yet stable multiple-breath inert gas washout (MBW) indices in patients with primary ciliary
dyskinesia (PCD). This study aimed to assess the intermediate term evolution and the between-
occasion variability of MBW indices in PCD over 1 year.
Methods: Children and young adults with a confirmed diagnosis of PCD were included in this
single-centre, prospective, observational, longitudinal study. Over 1 year, nitrogen (N2) MBW and
spirometry were performed at three occasions during ordinary scheduled outpatient visits. Trends
and variability in lung clearance index (LCI), moment ratios, normalized N2 concentration at six
lung volume turnovers, and regional ventilation inhomogeneity indices of the conducting and
intra-acinar airways (Scond*VT and Sacin*VT) were analysed using linear mixed models.
Results: Forty-two patients, aged 6–29 years (median: 15.4), performed 116 N2 MBW test occa-
sions and 96.6% were technically acceptable. A minimal, although significant, increase in LCI over
1 year (mean: 0.51 units, 95% CI: 0.12–0.91, p = 0.01) was found; while, all other N2 MBW indices
and FEV1 remained unchanged. A moderate correlation was observed between LCI and FEV1
(r = −0.47, p = 0.0001). The limits of agreement between tests 1 year apart were for LCI: −1.96 to
2.98; Scond*VT: ± 0.039; Sacin*VT: −0.108 to 0.128.
Conclusions: Children and young adults with PCD managed at a specialist centre showed
slightly, but significant, increasing LCI and otherwise unchanged ventilation inhomogeneity
indices and dynamic volumes over the intermediate term of 1 year. Estimates of the variability
of N2 MBW indices may inform sample size calculations of future randomized controlled trials.
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Introduction
The genetic, respiratory disease primary ciliary dyskinesia
(PCD) results from immotile or dyskinetic cilia, causing
defective mucociliary clearance. Accumulation of mucus,
bacteria, and debris in the airways gives rise to recurrent
respiratory tract infections, which may progress to
chronic infection and bronchiectasis [1–4]. PCD causes
progressive loss of lung function [5–7]. The aim of PCD
management is to maintain normal lung function and
prevent decline as long as possible [4]. The routine pro-
cedure for monitoring pulmonary function in school-
aged children and adults with PCD is spirometry [1,3].
However, spirometric measures of flow and volume are
primarily influenced by airway resistance of the larger
airways, which makes spirometry mostly sensitive for
detecting proximal airway disease [8]. Cross-sectional
studies of ventilation inhomogeneity, measured by multi-
ple-breath inert gas washout (MBW), in PCD have
demonstrated abnormal values [9–13], even in patients
with normal spirometric values [9,12] – reflecting periph-
eral airway involvement. The lung clearance index (LCI)
and the moment ratios (MRs), derived from MBW, are
measures of the overall ventilation distribution inhomo-
geneity in the lungs, of which the LCI is by far the most
commonly reported [8]. In recent years, several studies
[13–18] have investigated the possibilities of shortening
test duration without loss of sensitivity. A study from our
group [18] suggested the normalized concentration of
nitrogen (N2) when six lung volume turnovers have
been reached (Cn@TO6) as a possible endpoint for
abbreviation of the MBW test in school-aged children
with PCD. Besides measures of overall ventilation inho-
mogeneity, the MBW may provide insight into the
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mechanisms behind the ventilation inhomogeneity.
Thus, the indices Scond*VT and Sacin*VT are thought to
reflect the ventilation inhomogeneity arising in the small
conducting and acinar airways, respectively [8]. In a
cohort of 23 children and adolescents with PCD,
Scond*VT and Sacin*VT were abnormal in 96% and 78%,
respectively [9].
The intermediate term longitudinal trends and nat-
ural variability in MBW indices in PCD have not been
previously presented. Estimates of the between-occa-
sion variability of MBW indices are essential for
designing interventional studies utilizing the indices
as outcome measures.
The overall aim of this study was to assess the
intermediate term evolution and between-occasion
variability of N2 MBW indices in PCD patients based
on repeated measurements over 1 year. The primary
objective was to examine if the LCI changed over
1 year, and the secondary objective if MRs, Cn@TO6,
Scond*VT and Sacin*VT changed. The trends in the
forced expiratory volume in 1 s (FEV1), and the
FEV1/forced vital capacity (FVC) were simultaneously
evaluated for comparison.
Materials and methods
Study design
This was a single-centre, prospective, observational,
longitudinal study of PCD patients. Study procedures
were performed on three random visits within 1 year
when patients attended the outpatient clinic for sched-
uled routine visits.
Participants
School-aged children and young adults (aged >5 to
<30 years) with a confirmed diagnosis of PCD were
eligible for participation in the study and were
recruited from the national PCD centre in
Copenhagen, Denmark. Participants had to be clini-
cally stable at the baseline visit to be included.
Thereafter, study procedures were performed at the
patients’ routine clinic visits, regardless of clinical sta-
tus. Ongoing symptoms of upper and lower respiratory
tract exacerbation and antibiotic therapy at the test
occasions were recorded in the medical records and
in the case report forms. Participants were considered
to have exacerbation at a test occasion if they reported
ongoing worsening respiratory symptoms, which led to
the start of systemic antibiotic treatment within 1 week
before or at the visit.
Patients were considered to have chronic
Pseudomonas aeruginosa infection on a test occasion
if P. aeruginosa was cultured in ≥50% of the mucus
samples from the past year provided at least four
annual samples were filed.
Details of diagnosis and clinical management can be
found in the Supplementary material.
Study procedures
N2 MBW
The commercially available EXHALYZER® D and the
associated software SPIROWARE® version 3.1.6ext
(ECO MEDICS AG, Duernten, Switzerland) were uti-
lized for the N2 MBW measurements and calculation of
the N2 MBW indices. The N2 MBW was performed
according to the European Respiratory Society/
American Thoracic Society consensus statement [19].
The means of the N2 MBW indices from intentionally
three and at least two technically acceptable measure-
ments performed at each test occasion were reported in
absolute values. The N2 MBW indices of overall venti-
lation inhomogeneity evaluated in the study were LCI,
M1/M0 and M2/M0 (ratio of first to zeroth and second
to zeroth moment of the washout, respectively) [20],
and Cn@TO6. Ventilation inhomogeneity thought to
arise in the small conductive and acinar airway zones
were assessed by the concentration normalized phase
III slope indices Scond*VT and Sacin*VT (normalized
phase III slope indices multiplied by tidal volume to
account for differences in lung size and breathing pat-
tern) [19].
Results of the N2 MBW tests were unknown for
treating physicians, hence did not influence the clinical
management.
Spirometry
Dynamic lung volumes were measured by spirometry
(JAEGER MasterScreen, CareFusion, Hoechberg,
Germany) according to European Respiratory Society/
American Thoracic Society standards [21]. The percent
predicted values and z-scores were calculated using all-
ages prediction equations for spirometry from the
Global Lung Function Initiative [22].
Microbiological analysis of mucus
Mucus samples for microbiological analysis were collected
at all test occasions, preferably as sputum samples
obtained by expectoration. Laryngeal suction was used
for patients, who could not expectorate due to their
young age or low sputum production. Mucus samples
were included in the data analysis if they originated within
1 week before or after the test occasion, and the mucus
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samples were considered positive for bacteria if the cul-
ture was positive, regardless of the microscopy results.
Statistical analysis
Patient characteristics were presented by medians (ranges)
or numbers and percentages of total, as appropriate.
Pulmonary function variables were presented by means
(SD). For each pulmonary function variable, a linear
mixed model was applied to assess whether there was a
trend over time. The models included time on study as a
continuous fixed effect. To account for the repeated mea-
sures design, the models included patient as a random
effect. The analyses were adjusted for age at inclusion and
age at diagnosis as fixed effects. Due to a nonlinear effect
of age at diagnosis for some of the outcome variables, age
at diagnosis was modelled using B-splines [23]. The model
is described in more detail in the Supplementary material.
Based on the linear mixed models, intraclass corre-
lation coefficients (ICC) were calculated, and between-
occasion variability was determined as the limits of
agreement between two tests of the outcome variable
(further details in the Supplementary material). The
95% CI for ICC and limits of agreement were calcu-
lated using parametric bootstrap with B = 1000 boot-
strap samples, parametrically bootstrapping random
effects and residual errors [24].
The effect of possible time-dependent predictor vari-
ables was assessed by introducing these one by one in the
models: positive culture of any bacteria at the test occa-
sion (yes/no); positive culture of P. aeruginosa at the test
occasion (yes/no); chronic P. aeruginosa infection (yes/
no); and exacerbation at the test occasion (yes/no).
The correlation between the LCI and the FEV1 z-
score was determined from a joint model for the two
outcomes by combining the linear mixed models
described above and by introducing a correlation
between the two random intercepts as well as between
the two residual error terms [25].
We assumed missingness to be ‘missing at random’
(MAR), in which case analyses using linear mixed mod-
els are valid [26]. The statistical analyses were performed
using R version 3.3.1 (R Foundation for Statistical
Computing, Vienna, Austria) and using SAS version
9.4 (SAS Institute Inc., Cary, NC, USA). Two-sided p-
values <0.05 were considered statistically significant.
Ethics
The study was approved by The Committees on
Biomedical Research Ethics of the Capital Region of
Denmark (Protocol no.: H-1-2010-042). Informed con-
sent for participation in the study was obtained from all
participants or their parents/guardians if subjects were
aged <18 years prior to enrolment in the study.
Results
Forty-six patients treated for PCD agreed to participate in
the study. Of these, three patients did not fulfil the complete
diagnostic inclusion criteria for the study, and one patient
did notmeet the inclusion criterion of clinical stability at the
baseline visit. Six of the 42 included participants withdrew
from the study during the follow-up period (four patients
due to non-medical reasons and two patients due to infec-
tions with intensified treatment burden). Two additional
participants did not attend the intermediate test occasion.
Patient characteristics are shown in Table 1. There were 116
test occasions performed of which 100 (86.2%) had three
and 112 (96.6%) at least two acceptable N2 MBWmeasure-
ments. The median (interquartile range) time intervals
between the first and the second test occasion and between
the first and the third test occasion were 3.8 months (3.1–
5.5) and 12.3 months (11.9–13.1), respectively (Figure 1).
Pulmonary function variables are shown in Table 2.
The LCI changed minimally but significantly over time
(mean increase 0.51, 95% CI: 0.12–0.91, p = 0.01),
whereas MRs, Cn@TO6, Scond*VT, and Sacin*VT did
not change significantly over the 1-year observation
Table 1. Patient characteristics.
Baseline visit
(n = 42)
All visits
(No. of
visits = 116)
Sex (males/females) 16/26 (38%/62%)
Age (years) 15.4 (6.5−29.7)
Age at diagnosis (years) 6.6 (0.0−27.9)
Body mass index (kg/m2) 19.8 (13.7−39.0)
Diagnostics
Abnormal ciliary beat pattern and/
or frequency
42 (100%)
Abnormal ciliary ultra-structurea 35 (83.3%)
Abnormally low nasal NO
productionb
41 (97.6%)
Known pathogenic bi-allelic
mutationsc
13 (31.0%)
Microbiology
Available mucus samples 31 (73.8%) 93 (80.2%)
Positive culture samples 12 (38.7%) 62 (66.7%)
Haemophilus influenzae 6 (19.4%) 25 (26.8%)
Moraxella catarrhalis None 7 (7.5%)
Pseudomonas aeruginosa 2 (6.5%) 6 (6.5%)
Streptococcus pneumoniae 2 (6.5%) 13 (14.0%)
Staphylococcus aureus 2 (6.5%) 8 (8.6%)
Other bacteria None 3 (3.2%)
Chronic Pseudomonas aeruginosa
infection
3 (7.1%) 6 (5.2%)
Data are presented as No. (% of total or % of available mucus samples) or
median (range).
aDemonstrated by transmission electron microscopy or high-resolution
immunofluorescence (not including isolated inner dynein arm defects).
Three patients without visible abnormalities on routine transmission
electron microscopy were known to have the HYDIN mutation [27].
bNasal NO production <77 nl/min [28].
cMutational analysis of the entire cohort is ongoing.
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(Figure 2). There was no significant time trend in FEV1
z-score and FEV1/FVC z-score over the 1-year period.
When mutually adjusted for age at inclusion and age at
diagnosis, there was no effect of age at inclusion on any
of the pulmonary function parameters, whereas age at
diagnosis had a significant effect on M1/M0, M2/M0,
and Scond*VT. Five participants met the definition of
chronic P. aeruginosa infection at one or more test
occasions, which had a significant effect on M1/M0,
M2/M0, and Cn@TO6. Estimates of the effect of
chronic P. aeruginosa infection on M1/M0, M2/M0,
and Cn@TO6 were a mean increase (95% CI) of 0.31
(0.02–0.60), 4.15 (0.95–7.35), and 0.92 (0.04–1.80),
respectively. The presence of exacerbation at the test
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Figure 1. Time intervals between the repeated, longitudinal test occasions. Participants (n = 42) attended three test occasions over
a 1-year period during routine outpatient visits. Six of the 42 participants did not complete the follow-up occasions and two
participants did not attend the intermediate test occasion. The median time between the baseline and intermediate test occasion
and the baseline and last test occasion is indicated with a vertical line (interquartile ranges shown in dashed lines).
Table 2. Pulmonary function variables.
Baseline visit (n = 42) Last follow-up visit (n = 36) Trend
FEV1% predicted
a 83.5 (13.7) 85.2 (14.9) -
FEV1 z-score
a −1.38 (1.15) −1.24 (1.25) 0.02 (−0.18; 0.22)
p = 0.83
FVC % predicteda 94.1 (12.4) 95.9 (12.4) -
FVC z-scorea −0.50 (1.05) −0.35 (1.05) -
FEV1/FVC % predicted
a 88.1 (8.3) 88.1 (9.6) -
FEV1/FVC z-score
a −1.44 (0.92) −1.41 (1.06) 0.03 (−0.12; 0.17)
p = 0.72
LCI 10.20 (2.11) 10.46 (2.50) 0.51 (0.12; 0.91)
p = 0.01
M1/M0 2.32 (0.48) 2.34 (0.52) 0.06 (−0.04; 0.16)
p = 0.25
M2/M0 12.05 (4.87) 12.73 (6.34) 0.90 (−0.25; 2.04)
p = 0.12
Cn@TO6 5.70 (1.67) 5.60 (1.78) 0.16 (−0.14; 0.46)
p = 0.30
Scond*VT 0.062 (0.023) 0.062 (0.023) 0.002 (−0.005; 0.008)
p = 0.65
Sacin*VT 0.164 (0.101) 0.170 (0.109) 0.011 (−0.007; 0.028)
p = 0.22
Pulmonary function values are presented by means (SD). Trends in the pulmonary function variables over 1 year were
analysed with linear mixed models (including data on all 42 participants from the baseline visit and all available follow-up
data) and are presented with estimates of the mean difference and 95% CI (from basic statistical model only adjusted for
age at inclusion and age at diagnosis).
FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; LCI: lung clearance index; M1/M0: moment ratio to the first
degree; M2/M0: moment ratio to the second degree; Cn@TO6: normalized N2 concentration at six lung volume turnovers;
Scond*VT: regional ventilation inhomogeneity of the conducting airways corrected for tidal volume; Sacin*VT: regional
ventilation inhomogeneity of the intra-acinar airways corrected for tidal volume.
aReference values from Quanjer et al. Eur Respir J 2012 [22].
4 H. E. KOBBERNAGEL ET AL.
occasion (6.9% of the occasions) was the only covariate
that had a significant effect on FEV1 z-score (mean
decrease 0.65, 95% CI: 0.25–1.04, p = 0.002).
All N2 MBW indices, except Scond*VT, showed strong
ICC ranging from0.76 to 0.86 (Table 3). The Scond*VT had a
more moderate ICC. Estimates of between-occasion
variability for tests 1 year apart are shown in Table 3. The
variance parameters for each of the pulmonary function
variables can be found in Supplementary Table S1.
Excluding the test occasions where participants had
exacerbation from the analysis, did not change whether
the time trend in the N2 MBW indices and spirometric
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Figure 2. The individual longitudinal trends over 1 year in LCI, Scond*VT, and Sacin*VT. (a) LCI, (b) Scond*VT, and (c) Sacin*VT (n = 42).
The LCI, Scond*VT, and Sacin*VT are presented as absolute values. Time is presented in days. LCI: lung clearance index; Scond*VT:
regional ventilation inhomogeneity of the conducting airways corrected for tidal volume; Sacin*VT: regional ventilation inhomo-
geneity of the intra-acinar airways corrected for tidal volume.
Table 3. Intraclass correlation coefficients and between-occasion variability.
Between-occasion variability - 1 year between tests
Estimated ICC (95% CI) Estimated mean difference (SD of the difference) Limits of agreement (95% CI LL)/(95% CI UL)
FEV1 z-score 0.87 (0.78; 0.92) 0.02 (0.64) −1.23 to 1.27 (−1.52; −0.94)/(0.99; 1.53)
FEV1/FVC z-score 0.88 (0.80; 0.93) 0.03 (0.46) −0.87 to 0.93 (−1.09; −0.67)/(0.73; 1.12)
LCI 0.83 (0.71; 0.89) 0.51 (1.26) −1.96 to 2.98 (−2.49; −1.40)/(2.44; 3.56)
M1/M0 0.76 (0.62; 0.85) 0.06 (0.33) −0.59 to 0.71 (−0.72; −0.43)/(0.55; 0.85)
M2/M0 0.77 (0.63; 0.85) 0.90 (3.62) −6.20 to 8.00 (−7.78; −4.61)/(6.40; 9.72)
Cn@TO6 0.85 (0.74; 0.90) 0.16 (0.95) −1.70 to 2.02 (−2.10; −1.28)/(1.61; 2.46)
Scond*VT 0.53 (0.32; 0.68) 0.00 (0.02) −0.04 to 0.04 (−0.05; −0.03)/(0.03; 0.05)
Sacin*VT 0.86 (0.76; 0.91) 0.01 (0.06) −0.11 to 0.13 (−0.12; −0.07)/(0.10; 0.15)
Estimates of between-occasion variability were calculated as the limits of agreement between two test occasions with a 1-year interval and are presented
with the estimated mean difference in the outcome and SD of the difference, and the calculated limits of agreement with 95% CI on the lower and upper
limit of agreement, respectively.
ICC: intraclass correlation coefficient; LL: lower limit; UL: upper limit; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; LCI: lung clearance
index; M1/M0: moment ratio to the first degree; M2/M0: moment ratio to the second degree; Cn@TO6: normalized N2 concentration at six lung volume
turnovers; Scond*VT: regional ventilation inhomogeneity of the conducting airways corrected for tidal volume; Sacin*VT: regional ventilation inhomogeneity
of the intra-acinar airways corrected for tidal volume.
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lung function parameters was significant or not, and did
not narrow the between-occasion variability
(Supplementary Table S2).
There was a moderate correlation between the LCI
and FEV1 z-score (r = −0.47, p = 0.0001; Figure 3).
Discussion
This is the first report of longitudinal measurements and
variability of N2 MBW indices in PCD. The LCI increased;
whereas, MRs, Cn@TO6, Scond*VT and Sacin*VT did not
change significantly over 1 year in this cohort of children
and young adults managed at a national PCD specialist
centre. We found a moderate correlation between the LCI
and FEV1. This study provided estimates of the between-
occasion variability of N2 MBW indices, which are impor-
tant for designing future longitudinal interventional studies
of PCD utilizing N2 MBW indices as outcome measures.
For all N2 MBW outcomes, the ICC indicated strong cor-
relation between tests performed on the same patient,
although lower for Scond*VT than for the other indices.
Contrary to our finding, a pilot study by Irving et al
[29], which measured the LCI twice with 5-year inter-
val in 12 PCD patients, found no significant overall
change in the LCI. This difference might be because
Irving’s study group was simply too small to find the
rather small increase in LCI, which we demonstrated;
another tracer gas was used (sulphur hexafluoride); the
patient cohorts might be different with respect to age,
infection status, or other disease characteristics; or
management practices might be different. The PCD
patients participating in the present study were young
and the majority diagnosed in their childhood. We
found that age at diagnosis had an effect on some of
the N2 MBW indices, though not on the LCI or
Sacin*VT, which is consistent with previous cross-sec-
tional studies that did not find a significant association
with age at diagnosis [9,12]. The presence of chronic P.
aeruginosa infection might also affect the N2 MBW
indices towards higher values. However, the proportion
of test occasions where participants met the definition
of chronic P. aeruginosa infection was small. Prolonged
infection with P. aeruginosa may be less persistent in
PCD than in cystic fibrosis [30]. The impact of P.
aeruginosa infection on pulmonary function in PCD
remains unclear, since currently only a few studies have
demonstrated significantly more abnormal pulmonary
function in PCD patients with P. aeruginosa infection
compared with patients without [7,31,32]. Recently,
two cross-sectional studies in PCD demonstrated rela-
tionship between phenotype assessed by lung function
and ultrastructural defects and genotype [33,34]. Davis
et al. [33] showed that children with central apparatus
defects with microtubular disorganization had worse
FEV1 than patients with outer dynein arm or outer-
plus inner dynein arm defects and similar when limited
to the patients with biallelic mutations in the PCD-
associated genes CCDC39 or CCDC40 compared with
gene mutations associated with outer dynein arm or
outer- plus inner dynein arm defects [33], and Irving et
al. [34] found more abnormal LCI in PCD patients
with microtubular defects compared with patients
with dynein arm defects and patients with normal
ultrastructure. We were not able to compare the seve-
rities of ventilation inhomogeneity between subgroups
with different genetic mutations in this study due to
the limited number of participants and limited number
with known genetic mutations.
In the present study, we found a moderate negative
correlation between LCI and FEV1, similar to cross-sec-
tional studies on PCD by Boon et al. [12] and Nyilas et al.
[35]. Twoprevious cross-sectional studies of LCI in children
with PCD at our centre did not find a significant correlation
between FEV1 and LCI [9,18], consistent with a study by
Irving et al. [11]. These discrepant findings and also the
contradictory results on correlations between the LCI and
high-resolution computed tomography scores have led to
discussions about the usefulness of MBW in PCD
[11,12,36]. The fact that the LCI is abnormal in most
patients with PCD, including patients with normal FEV1
[9,12], indicates that MBW does provide additional infor-
mation to FEV1 by reflecting peripheral airway disease,
which is not fully assessable by spirometry.
A strength of this study is that the longitudinal trends in
N2MBW indices were based on several follow-upmeasure-
ments, and that the longitudinal design makes it possible to
estimate the ICC and limits of agreements of the pulmonary
function outcomes. One limitation is that the study was not
conducted in a strict controlled manner since the study
procedures were performed as part of routine clinical visits;
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Figure 3. Association between LCI and FEV1 z-score (r = −0.47,
p = 0.0001), data from all test occasions. The LCI is presented
as absolute values. LCI: lung clearance index; FEV1: forced
expiratory volume in 1 sec.
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therefore, not all patients were clinically stable at the follow-
up visits. On the other hand, an observational study like this
more truly reflects the natural course of pulmonary function
in PCD patients. The presence of exacerbation on the test
occasionwas included in the statistical models as a covariate
and had no significant effect on theN2MBWoutcomes and
excluding the test occasions with exacerbation from the
analysis did not alter whether there was a time trend in the
indices or change the limits of agreement. The data collected
in the current study are not appropriate for investigating the
direct impact of acute exacerbations on MBW indices in
PCD. Another limitation is the rather small sample size,
considering the wide age range. However, PCD is rare, and
the present sample size is quite large for a single-centre study
within the age range represented. The limits of agreement
reported in this study are, formany of the outcomes, subject
to some uncertainty due to the limited number of patients.
Management and treatment practices in PCD vary, even
within Europe [37]; since this is a single-centre study, the
estimates of variability may require confirmation in PCD
cohorts with different management practices and in multi-
centre studies. Moreover, longitudinal trends and between-
occasion variability in healthy subjects are warranted.
In conclusion, this is the first study to report intermedi-
ate term longitudinal trends and variability of N2 MBW
indices in PCD. Children and young adults with PCD
managed at a specialist centre showed overall a minimal
but significant increasing LCI and otherwise persistently
mild to severe abnormal ventilation inhomogeneity indices
over 1 year. The increase in LCImay reflect disease progres-
sion and/or natural fluctuations. The N2 MBW indices
seem to be promising clinical outcome measures in PCD,
according to their ICC. Estimates of the variability may be
useful for interpretation of changes in N2 MBW indices in
routine management of PCD and for future interventional
studies utilizing N2 MBW indices as outcome measures.
However, the longitudinal trends in MBW indices need to
be confirmed in future studies investigating the trends over
longer follow-up periods and in larger patient cohorts
including all ages and in healthy subjects, where to our
knowledge only cross-sectional data exist. In addition, stu-
dies should assess whether time trends in MBW indices
may depend on disease severity, infection status, or disease
characteristics such as underlying genotype.
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